Abstract

Purpose of the study Antiretroviral (ARV) regimens may be statistically noninferior in clinical trials, but have very different economic outcomes due to differences in costs and adverse event profiles. Given the heavy cost burden of HIV disease, it is important to consider economic issues when selecting an ARV regimen. This study examines the cost and consequences of initiating an ARV regimen including LPV/r or EFV, using data from a recent clinical trial in a previously published model of HIV-disease.

Highlights

  • Initiating an LPV/r-containing regimen on ARV-naive patients appears cost-effective compared to an EFV-based regimen, when the cost and consequences of lipoatrophy are include

  • Economic modeling of the combined effects of HIV disease, heart disease and lipoatrophy based on ACTG 5142 trial data

  • Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1758-2652-11-S1-info.pdf

Read more

Summary

Open Access

Economic modeling of the combined effects of HIV disease, heart disease and lipoatrophy based on ACTG 5142 trial data. Address: 1Medical University of South Carolina, Charleston, USA, 2Abbott Health Economics and Outcomes Research, Abbott Park, USA, 3Abbott GmbH & Co, Ludwigshafen, Germany, 4Abbott Laboratories, North Chicago, USA, 5University of Pittsburg, Pittsburg, USA and 6University of California at San Diego, San Diego, USA. Published: 10 November 2008 Journal of the International AIDS Society 2008, 11(Suppl 1):P312 doi:10.1186/1758-2652-11-S1-P312. Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1758-2652-11-S1-info.pdf

Purpose of the study
Methods
Summary of results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.